1. Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells?

   • Alexander M. Scherbakov
   • Yulia S. Lobanova
   • Mikhail A. Krasil’nikov

   Preclinical study 20 September 2006 Pages: 1 - 11

2. GnRH analogs reduce invasiveness of human breast cancer cells

   • Julia von Alten
   • Stefanie Fister
   • Carsten Gründker

   Preclinical Study 07 June 2006 Pages: 13 - 21

3. Assessment of multiple different estrogen receptor-β antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions

   • Gregory E. Weitsman
   • George Skliris
   • Leigh C. Murphy

   Preclinical study 17 May 2006 Pages: 23 - 31

4. Proteasome Inhibitors Induce a p38 Mitogen-activated Protein Kinase (MAPK)-dependent Anti-apoptotic Program Involving MAPK Phosphatase-1 and Akt in Models of Breast Cancer

   • Yue Y. Shi
   • George W. Small
   • Robert Z. Orlowski

   Preclinical Study 29 June 2006 Pages: 33 - 47

5. Secreted Frizzled Related Protein 2 (sFRP2) Decreases Susceptibility to UV-Induced Apoptosis in Primary Culture of Canine Mammary Gland Tumors by NF-κB Activation or JNK Suppression

   • Jia-Lin Lee
   • Ching-Jin Chang
   • Chung-Tien Lin

   Preclinical Study 22 June 2006 Pages: 49 - 58

6. Premature Menopause in Patients with BRCA1 Gene Mutation

   • Izabella Rzepka-Górska
   • Bogusław Tarnowski
   • Aleksandra Tołoczko-Grabarek

   Clinical Trial 14 June 2006 Pages: 59 - 63

7. Cosmetic outcomes following breast conservation therapy: in search of a reliable scale

   • Amanda J. Fortin
   • Mary Cheang
   • Steven Latosinsky

   CLINICAL STUDY 04 July 2006 Pages: 65 - 70

8. Estrogen Receptor Expression in Benign Breast Ductal Cells Obtained from Random Periareolar Fine Needle Aspiration Correlates with Menopausal Status and Cytomorphology Index Score

   • Priyanka Sharma
   • Bruce F. Kimler
   • Carol J. Fabian

   Clinical trial 22 June 2006 Pages: 71 - 76

9. Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer

   • R. Asola
   • H. Huhtala
   • K. Holli

   Epidemiology 07 June 2006 Pages: 77 - 82

10. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families

    • Giuseppe Giannini
    • Carlo Capalbo
    • Alberto Gulino

    Epidemiology 09 May 2006 Pages: 83 - 91

11. Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits

    • Szu-Hsien Wu
    • Shih-Meng Tsai
    • Li-Yu Tsai

    Epidemiology 07 June 2006 Pages: 93 - 98

12. CHEK2 1100delC mutation is frequent among Russian breast cancer patients

    • Elena V. Chekmariova
    • Anna P. Sokolenko
    • Evgeny N. Imyanitov

    Epidemiology 07 June 2006 Pages: 99 - 102

13. Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women

    • Pamela J. VandeVord
    • Paul H. Wooley
    • Dorothy A. Nelson

    Epidemiology 22 June 2006 Pages: 103 - 107

14. Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast Cancer

    • Mieke Kriege
    • Cecile T. M. Brekelmans
    • Jan G. M. Klijn

    Epidemiology 22 June 2006 Pages: 109 - 119

15. Effects of Estrogen Receptor Expression and Histopathology on Annual Hazard Rates of Death from Breast Cancer

    • William F. Anderson
    • Bingshu E. Chen
    • Philip S. Rosenberg

    Original Report 10 May 2006 Pages: 121 - 126